BioSpace News Archive

Policy

Breakthrough Device Designation received from the FDA

Accelerated regulatory pathway for first internal use product

June 18, 2019
·
4 min read
Deals

Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Asabys Partners

Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases

June 18, 2019
·
5 min read
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market worth USD 236.46 Million, at 7% CAGR During 2019-2023 | Technavio

According to Technavio Research Report “Human Immunodeficiency Virus Rapid Test Kits Market by end-user, and geographic regions is witnessed to grow USD 236.46 million, at a CAGR of 7% from 2019 to 2023”.

June 18, 2019
·
4 min read
Drug Development

Aclaris Therapeutics Announces Positive 6-Month Results from a Phase 2 Open-Label Clinical Trial of ATI-502 Topical in Patients with Androgenetic Alopecia (Male/Female Pattern-Baldness)

The trial evaluated ATI-502 in women and men with AGA. Subjects aged 18-50 years applied ATI-502 to their scalp twice daily for 26 weeks.

June 18, 2019
·
6 min read
Policy

Health Canada Approves Hemlibra® for Hemophilia A Patients Without Factor VIII Inhibitors

Hemlibra is the only treatment that can be self-injected subcutaneously once weekly for patients with hemophilia A without factor VIII inhibitors1

June 18, 2019
·
11 min read
Policy

FDA Office of Regulatory Affairs and Salient CRGT Receive 2019 FedHealthIT Innovation Award for the FDA Data Dashboard

Salient CRGT announced that its client, the FDA Office of Regulatory Affairs, has received a FedHealthIT Innovation Award for the FDA Data Dashboard.

June 18, 2019
·
2 min read
Job Trends

Soliton to be Added to the Russell 2000 and 3000 Indexes on June 28, 2019

Soliton, Inc. announced that the company will be added to the Russell 2000® and 3000® Indexes, effective after the market close on Friday, June 28, 2019, as part of the Russell Indexes annual reconstitution.

June 18, 2019
·
3 min read
Policy

Avalon GloboCare Expected to Join the Russell 3000® Index

Avalon GloboCare Corp. announced that it expects to be added to the Russell 3000® Index, based on a preliminary list of additions posted June 7, 2019.

June 18, 2019
·
4 min read
Biotech Beach

Biocept Announces Commercial Launch of Target Selector™ NGS Breast Panel, the Company’s Second Multi-Gene Tumor-Specific Panel

Biocept continues to expand its commercial offering for breast cancer and remains the only liquid biopsy provider to offer single-biomarker testing, tumor-specific panels, and circulating tumor cell analysis

June 18, 2019
·
8 min read
Genetown

Moderna to Present at BMO 2019 Prescriptions for Success Healthcare Conference

Moderna, Inc. announced that Pamela Cohen, M.D., Head, Clinical Oncology Development, will present at the BMO 2019 Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 3:20 p.m. ET.

June 18, 2019
·
2 min read